세계의 의약품용 금속 감지기 시장 : 제품별, 기술별, 용도별, 최종 사용자별, 지역별 예측(-2030년)

The global pharmaceutical metal detectors market is projected to reach USD 197.7 million by 2030 from USD 157.1 million in 2025, registering a CAGR of 4.7% during the forecast period. The growth is primarily driven by stringent regulatory requirements for product safety and the rising demand for contamination-free pharmaceutical products. Increasing cases of product recalls and quality-related concerns have compelled manufacturers to adopt advanced detection technologies.

The growing integration of automated and intelligent metal detection systems, coupled with innovations in sensor sensitivity and real-time monitoring, is further expected to boost market expansion. Emphasis on compliance with GMP and FDA standards also encourages pharmaceutical companies to invest in high-precision inspection equipment. Moreover, industry players are increasingly engaging in product innovation and strategic collaborations to enhance their competitive edge and ensure process reliability.

By product type, the tablet metal detectors segment accounted for the largest market share in 2024.

Tablet metal detectors dominated the pharmaceutical metal detectors market in 2024, primarily due to the widespread production of tablets across the global pharmaceutical industry. Tablets remain the most preferred and commonly manufactured solid dosage form because of their convenience, long shelf life, and patient compliance. The ease of integration, cost-efficiency, and reliability of tablet metal detectors have led to their wide adoption by both large pharmaceutical manufacturers and contract manufacturing organizations (CMOs). With rising global drug demand and tighter quality controls, the use of tablet metal detectors continues to expand, solidifying their position as the leading product type in this market.

By technology, the magnetic field detectors segment accounted for the largest share of the market in 2024.

Magnetic field detectors held the largest share of the pharmaceutical metal detectors market in 2024 due to their proven effectiveness, cost-efficiency, and adaptability across various pharmaceutical applications. Magnetic field detectors require less capital than more advanced systems like X-ray or multi-frequency detectors. For many pharmaceutical manufacturers, especially those operating in cost-sensitive or emerging markets, this affordability, paired with performance, makes magnetic field technology the preferred choice. Altogether, their combination of precision, versatility, and economic value solidifies their dominance in the pharmaceutical metal detectors market.

By region, North America is expected to witness the highest growth rate during the forecast period.

The key factors driving market growth in North America include a high level of technological adoption and automation in pharmaceutical manufacturing facilities. This environment supports the integration of advanced metal detection systems that feature real-time data tracking, AI-based calibration, and automated rejection systems. Higher R&D spending and early adoption of Industry 4.0 practices have driven the use of multi-frequency and magnetic field detectors across North American facilities. This focus on innovation and operational efficiency further boosts the regional demand. The increasing number of drug recalls due to contamination risks and the growing export volume of US- and Canada-manufactured pharmaceutical products also necessitate robust inspection protocols, further reinforcing the dominance of North America in the pharmaceutical metal detectors market.

Breakdown of supply-side primary interviews:

• By Company Type: Tier 1 (45%), Tier 2 (20%), and Tier 3 (35%)
• By Designation: C-level Executives (35%), Directors (25%), and Others (40%)
• By Region: North America (40%), Europe (25%), Asia Pacific (20%), Latin America (10%), and the Middle East & Africa (5%)

Breakdown of demand-side primary interviews:

• By Company Type: Pharmaceutical Companies (50%), CDMOs (25%), Biopharmaceutical Companies (15%), and Other End Users (10%)
• By Designation: Heads of Manufacturing/Production (40%), Quality Assurance Managers (30%), Regulatory Compliance Officers (20%), and Other Designations (10%)
• By Region: North America (40%), Europe (25%), Asia Pacific (20%), Latin America (10%), and the Middle East & Africa (5%)

Research Coverage

This report studies the pharmaceutical metal detectors market by product, technology, application, end user, and region. The report also studies factors affecting market growth (drivers, restraints, opportunities, and challenges). It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Additionally, the report examines micromarkets concerning their growth trends and predicts the revenue of the market segments across four key regions and their respective countries.

Reasons to Buy the Report

The report can assist both established and smaller firms in assessing the market, which would enable them to capture a larger share. Companies that purchase the report could utilize one or a combination of the five strategies outlined below.

This report provides insights into the following pointers:

• Analysis of key drivers (growing number of product recalls due to metal contamination, stringent regulatory compliance mandates by regulatory authorities, and growing adoption of automation and inline quality control systems), restraints (high initial capital expenditure and recurring maintenance costs and operational challenges in detecting non-ferrous and foil-based contaminants), opportunities (focus on production optimization and high R&D investments and expansion of pharmaceutical exports and contract manufacturing), and challenges (integration complexity with existing production lines) are expected to influence the growth of the pharmaceutical metal detectors market.
• Product Development/Innovation: Detailed insights into upcoming technologies, R&D activities, and product launches in the pharmaceutical metal detectors market.
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for several types of pharmaceutical metal detection processes across regions.
• Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the pharmaceutical metal detectors market.
• Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the pharmaceutical metal detectors market.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE
  • 1.3.2 INCLUSIONS & EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
• 1.4 CURRENCY
• 1.5 STAKEHOLDERS

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH APPROACH
  • 2.1.1 SECONDARY DATA
  • 2.1.2 PRIMARY DATA
• 2.2 MARKET SIZE ESTIMATION
• 2.3 MARKET BREAKDOWN & DATA TRIANGULATION
• 2.4 MARKET SHARE ESTIMATION
• 2.5 STUDY ASSUMPTIONS
• 2.6 RISK ASSESSMENT
• 2.7 RESEARCH LIMITATIONS
  • 2.7.1 METHODOLOGY-RELATED LIMITATIONS
  • 2.7.2 SCOPE-RELATED LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 PHARMACEUTICAL METAL DETECTORS MARKET OVERVIEW
• 4.2 NORTH AMERICA: PHARMACEUTICAL METAL DETECTORS MARKET OVERVIEW
• 4.3 PHARMACEUTICAL METAL DETECTORS MARKET: REGIONAL MIX
• 4.4 PHARMACEUTICAL METAL DETECTORS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES
• 4.5 PHARMACEUTICAL METAL DETECTORS MARKET: DEVELOPING VS. DEVELOPED ECONOMIES

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Growing number of product recalls due to metal contamination
    • 5.2.1.2 Stringent regulatory compliance mandates
    • 5.2.1.3 Growing adoption of automation and inline quality control systems
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 High initial capital expenditure and recurring maintenance costs
    • 5.2.2.2 Operational challenges in detecting non-ferrous and foil-based contaminants
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Focus on production optimization and high R&D investment
    • 5.2.3.2 Expansion of pharmaceutical exports and contract manufacturing
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Integration complexity with existing production lines
• 5.3 TECHNOLOGY ANALYSIS
  • 5.3.1 KEY TECHNOLOGIES
    • 5.3.1.1 Electromagnetic induction technology
    • 5.3.1.2 Multi frequency detection
  • 5.3.2 COMPLEMENTARY TECHNOLOGIES
    • 5.3.2.1 Conveyor and reject mechanism systems
    • 5.3.2.2 Human-machine interface (HMI) and touchscreen controls
• 5.4 PORTER'S FIVE FORCES ANALYSIS
  • 5.4.1 INTENSITY OF COMPETITIVE RIVALRY
  • 5.4.2 BARGAINING POWER OF BUYERS
  • 5.4.3 BARGAINING POWER OF SUPPLIERS
  • 5.4.4 THREAT OF SUBSTITUTES
  • 5.4.5 THREAT OF NEW ENTRANTS
• 5.5 REGULATORY ANALYSIS
  • 5.5.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.5.2 REGULATORY FRAMEWORK
    • 5.5.2.1 North America
      • 5.5.2.1.1 US
      • 5.5.2.1.2 Canada
    • 5.5.2.2 Europe
      • 5.5.2.2.1 Germany
    • 5.5.2.3 Asia Pacific
      • 5.5.2.3.1 China
      • 5.5.2.3.2 Japan
      • 5.5.2.3.3 India
      • 5.5.2.3.4 Australia
    • 5.5.2.4 Rest of the World
• 5.6 PATENT ANALYSIS
  • 5.6.1 INSIGHTS ON PATENT PUBLICATION TRENDS, TOP APPLICANTS, AND JURISDICTION FOR PHARMACEUTICAL METAL DETECTORS MARKET, JANUARY 2015-MAY 2025
  • 5.6.2 LIST OF MAJOR PATENTS, 2023-2024
• 5.7 TRADE ANALYSIS
  • 5.7.1 IMPORT DATA FOR HS CODE 854370, 2020-2024
  • 5.7.2 EXPORT DATA FOR HS CODE 854370, 2020-2024
• 5.8 KEY CONFERENCES & EVENTS, 2025-2026
• 5.9 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.9.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.9.2 KEY BUYING CRITERIA
• 5.10 PRICING ANALYSIS
  • 5.10.1 INDICATIVE PRICING ANALYSIS OF KEY PLAYERS, BY PRODUCT TYPE, 2022-2024
  • 5.10.2 INDICATIVE PRICING ANALYSIS OF PHARMACEUTICAL METAL DETECTORS, BY REGION, 2022-2024
• 5.11 VALUE CHAIN ANALYSIS
• 5.12 ECOSYSTEM ANALYSIS
• 5.13 IMPACT OF AI/GEN AI ON PHARMACEUTICAL METAL DETECTORS MARKET
• 5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 5.15 INVESTMENT & FUNDING SCENARIO
• 5.16 IMPACT OF 2025 US TARIFF ON PHARMACEUTICAL METAL DETECTORS MARKET
  • 5.16.1 INTRODUCTION
  • 5.16.2 KEY TARIFF RATES
  • 5.16.3 PRICE IMPACT ANALYSIS
  • 5.16.4 IMPACT ON COUNTRY/REGION
    • 5.16.4.1 US
    • 5.16.4.2 Europe
    • 5.16.4.3 APAC
  • 5.16.5 IMPACT ON END-USE INDUSTRIES
    • 5.16.5.1 Pharmaceutical companies
    • 5.16.5.2 Contract Development and Manufacturing Organizations (CDMOs)
    • 5.16.5.3 Other end users

6 PHARMACEUTICAL METAL DETECTORS MARKET, BY PRODUCT

• 6.1 INTRODUCTION
• 6.2 TABLET METAL DETECTORS
  • 6.2.1 TABLET METAL DETECTORS TO DOMINATE MARKET DUE TO HIGH DEPLOYMENT IN LINE WITH TABLET PRESSES
• 6.3 CAPSULE METAL DETECTORS
  • 6.3.1 INCREASING NEED FOR PRECISION DURING CAPSULE FILLING AND PACKAGING TO BOOST ADOPTION
• 6.4 POWDER METAL DETECTORS
  • 6.4.1 HIGH RISK OF CONTAMINATION IN DRY BULK PROCESSING TO DRIVE ADOPTION OF POWDER METAL DETECTORS
• 6.5 LIQUID METAL DETECTORS
  • 6.5.1 INCREASING USE IN SYRUPS AND SUSPENSIONS REQUIRING BATCH PURITY TO SUPPORT MARKET GROWTH
• 6.6 PIPELINE METAL DETECTORS
  • 6.6.1 GROWING POPULARITY DUE TO EFFICIENCY IN CONTINUOUS FLOW SYSTEMS FOR SEMI-SOLIDS AND LIQUIDS TO FUEL MARKET GROWTH

7 PHARMACEUTICAL METAL DETECTORS MARKET, BY TECHNOLOGY

• 7.1 INTRODUCTION
• 7.2 MAGNETIC FIELD DETECTORS
  • 7.2.1 VERSATILITY OF MAGNETIC FIELD DETECTORS ACROSS VARIOUS PRODUCT TYPES AND PACKAGING FORMATS TO BOOST ADOPTION
• 7.3 MULTI-FREQUENCY DETECTORS
  • 7.3.1 NEED FOR HIGH SENSITIVITY IN MIXED PRODUCT LINES TO BOOST DEMAND FOR MULTI-FREQUENCY METAL DETECTORS
• 7.4 X-RAY INSPECTION WITH METAL DETECTORS
  • 7.4.1 SUPERIOR PERFORMANCE IN DETECTING DENSE AND NON-METALLIC CONTAMINANTS TO SUPPORT MARKET GROWTH
• 7.5 OTHER TECHNOLOGIES

8 PHARMACEUTICAL METAL DETECTORS MARKET, BY APPLICATION

• 8.1 INTRODUCTION
• 8.2 QUALITY CONTROL
  • 8.2.1 STRINGENT GMP GUIDELINES EMPHASIZING END-TO-END PRODUCT INSPECTION TO CONTRIBUTE TO MARKET GROWTH
• 8.3 CONTAMINANT DETECTION
  • 8.3.1 GROWING PRODUCT RECALLS AND HEALTH RISKS TO BOOST GROWTH
• 8.4 PACKAGING
  • 8.4.1 RISING USE OF INLINE DETECTORS IN HIGH-SPEED PRODUCTION LINES TO SUPPORT MARKET GROWTH
• 8.5 COMPLIANCE
  • 8.5.1 TIGHTER GLOBAL REGULATIONS AND INCREASED AUDIT PREPAREDNESS TO DRIVE GROWTH IN MARKET

9 PHARMACEUTICAL METAL DETECTORS MARKET, BY END USER

• 9.1 INTRODUCTION
• 9.2 PHARMACEUTICAL COMPANIES
  • 9.2.1 HIGH VOLUME OF DRUG MANUFACTURING ACTIVITIES AND STRINGENT QA PROTOCOLS TO DRIVE GROWTH
• 9.3 CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS (CDMOS)
  • 9.3.1 STRONG OUTSOURCING DEMAND TO PROPEL CDMO SEGMENTAL GROWTH
• 9.4 BIOPHARMACEUTICAL COMPANIES
  • 9.4.1 RAPID EXPANSION OF BIOLOGICS MANUFACTURING CAPACITY TO BOOST METAL DETECTOR USAGE IN BIOPHARMACEUTICAL FIRMS
• 9.5 OTHER END USERS

10 PHARMACEUTICAL METAL DETECTORS MARKET, BY REGION

• 10.1 INTRODUCTION
• 10.2 NORTH AMERICA
  • 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 10.2.2 US
    • 10.2.2.1 Stringent FDA enforcement and contamination recalls to propel metal detector demand in US
  • 10.2.3 CANADA
    • 10.2.3.1 National biomanufacturing strategy to spur metal detector integration in Canada
• 10.3 EUROPE
  • 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 10.3.2 GERMANY
    • 10.3.2.1 Robust R&D and manufacturing excellence to drive market
  • 10.3.3 UK
    • 10.3.3.1 Rising quality-driven inspection spending to boost market
  • 10.3.4 FRANCE
    • 10.3.4.1 Government-backed reshoring efforts and sterile drug production to propel demand for metal detectors in France
  • 10.3.5 ITALY
    • 10.3.5.1 Country's biopharmaceutical growth to support market uptake
  • 10.3.6 SPAIN
    • 10.3.6.1 Public-sector manufacturing expansion and generics uptake to boost metal detector demand
  • 10.3.7 REST OF EUROPE
• 10.4 ASIA PACIFIC
  • 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 10.4.2 CHINA
    • 10.4.2.1 Booming biologics hubs to fuel market growth in China
  • 10.4.3 JAPAN
    • 10.4.3.1 Aging population and universal health coverage to drive adoption
  • 10.4.4 INDIA
    • 10.4.4.1 Surging compliance upgrades and massive export ambitions to drive adoption
  • 10.4.5 AUSTRALIA
    • 10.4.5.1 Advanced pharmaceutical manufacturing to drive quality-centric investments
  • 10.4.6 SOUTH KOREA
    • 10.4.6.1 Innovation-driven pharma sector to promote advanced quality assurance
  • 10.4.7 REST OF ASIA PACIFIC
• 10.5 REST OF THE WORLD
  • 10.5.1 MACROECONOMIC OUTLOOK FOR REST OF THE WORLD

11 COMPETITIVE LANDSCAPE

• 11.1 OVERVIEW
• 11.2 KEY PLAYER STRATEGY/RIGHT TO WIN
• 11.3 REVENUE ANALYSIS, 2022-2024
• 11.4 MARKET SHARE ANALYSIS, 2024
• 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
  • 11.5.1 STARS
  • 11.5.2 EMERGING LEADERS
  • 11.5.3 PERVASIVE PLAYERS
  • 11.5.4 PARTICIPANTS
  • 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
    • 11.5.5.1 Company footprint
    • 11.5.5.2 Region footprint
    • 11.5.5.3 Product footprint
    • 11.5.5.4 Technology footprint
    • 11.5.5.5 Application footprint
• 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
  • 11.6.1 PROGRESSIVE COMPANIES
  • 11.6.2 RESPONSIVE COMPANIES
  • 11.6.3 DYNAMIC COMPANIES
  • 11.6.4 STARTING BLOCKS
  • 11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
    • 11.6.5.1 Detailed list of key startup/SME players
    • 11.6.5.2 Competitive benchmarking of key emerging players/startups
• 11.7 BRAND/PRODUCT COMPARISON
• 11.8 R&D EXPENDITURE OF KEY PLAYERS
• 11.9 COMPANY VALUATION & FINANCIAL METRICS
  • 11.9.1 FINANCIAL METRICS
  • 11.9.2 COMPANY VALUATION
• 11.10 COMPETITIVE SCENARIO
  • 11.10.1 PRODUCT LAUNCHES
  • 11.10.2 DEALS
  • 11.10.3 EXPANSIONS
  • 11.10.4 OTHER DEVELOPMENTS

12 COMPANY PROFILES

• 12.1 KEY PLAYERS
  • 12.1.1 METTLER-TOLEDO INTERNATIONAL INC.
    • 12.1.1.1 Business overview
    • 12.1.1.2 Products offered
    • 12.1.1.3 MnM view
      • 12.1.1.3.1 Right to win
      • 12.1.1.3.2 Strategic choices
      • 12.1.1.3.3 Weaknesses & competitive threats
  • 12.1.2 THERMO FISHER SCIENTIFIC INC.
    • 12.1.2.1 Business overview
    • 12.1.2.2 Products offered
    • 12.1.2.3 MnM view
      • 12.1.2.3.1 Right to win
      • 12.1.2.3.2 Strategic choices
      • 12.1.2.3.3 Weaknesses & competitive threats
  • 12.1.3 ANRITSU CORPORATION
    • 12.1.3.1 Business overview
    • 12.1.3.2 Products offered
    • 12.1.3.3 Recent developments
      • 12.1.3.3.1 Product launches
    • 12.1.3.4 MnM view
      • 12.1.3.4.1 Right to win
      • 12.1.3.4.2 Strategic choices
      • 12.1.3.4.3 Weaknesses & competitive threats
  • 12.1.4 MINEBEAMITSUMI INC.
    • 12.1.4.1 Business overview
    • 12.1.4.2 Products offered
    • 12.1.4.3 Recent developments
      • 12.1.4.3.1 Product launches
  • 12.1.5 ILLINOIS TOOL WORKS INC.
    • 12.1.5.1 Business overview
    • 12.1.5.2 Products offered
    • 12.1.5.3 Recent developments
      • 12.1.5.3.1 Product launches
  • 12.1.6 ERIEZ MANUFACTURING CO.
    • 12.1.6.1 Business overview
    • 12.1.6.2 Products offered
    • 12.1.6.3 Recent developments
      • 12.1.6.3.1 Deals
      • 12.1.6.3.2 Other developments
    • 12.1.6.4 MnM view
      • 12.1.6.4.1 Right to win
      • 12.1.6.4.2 Strategic choices
      • 12.1.6.4.3 Weaknesses & competitive threats
  • 12.1.7 CEIA S.P.A.
    • 12.1.7.1 Business overview
    • 12.1.7.2 Products offered
    • 12.1.7.3 Recent developments
      • 12.1.7.3.1 Product launches
      • 12.1.7.3.2 Expansions
    • 12.1.7.4 MnM view
      • 12.1.7.4.1 Right to win
      • 12.1.7.4.2 Strategic choices
      • 12.1.7.4.3 Weaknesses & competitive threats
  • 12.1.8 FORTRESS TECHNOLOGY INC.
    • 12.1.8.1 Business overview
    • 12.1.8.2 Products offered
    • 12.1.8.3 Recent developments
      • 12.1.8.3.1 Product launches
      • 12.1.8.3.2 Deals
  • 12.1.9 CASSEL MESSTECHNIK GMBH
    • 12.1.9.1 Business overview
    • 12.1.9.2 Products offered
    • 12.1.9.3 Recent developments
      • 12.1.9.3.1 Product launches
  • 12.1.10 BUNTING
    • 12.1.10.1 Business overview
    • 12.1.10.2 Products offered
  • 12.1.11 NIKKA DENSOK LIMITED
    • 12.1.11.1 Business overview
    • 12.1.11.2 Products offered
  • 12.1.12 PRISMA INDUSTRIALE S.R.L.
    • 12.1.12.1 Business overview
    • 12.1.12.2 Products offered
  • 12.1.13 WIPOTEC GMBH
    • 12.1.13.1 Business overview
    • 12.1.13.2 Products offered
  • 12.1.14 DONGGUAN COSO ELECTRONIC TECH CO., LTD.
    • 12.1.14.1 Business overview
    • 12.1.14.2 Products offered
  • 12.1.15 VINSYST TECHNOLOGIES
    • 12.1.15.1 Business overview
    • 12.1.15.2 Products offered
• 12.2 OTHER PLAYERS
  • 12.2.1 SED PHARMA
  • 12.2.2 NEMESIS SRL
  • 12.2.3 SOLLAU S.R.O.
  • 12.2.4 TECHNOFOUR ELECTRONICS PVT. LTD.
  • 12.2.5 INOS
  • 12.2.6 ACG
  • 12.2.7 ULTRACON ENGIMECH PVT. LTD.
  • 12.2.8 DAS ELECTRONICS
  • 12.2.9 UNIQUE EQUIPMENT
  • 12.2.10 LODHA INTERNATIONAL LLP

13 APPENDIX

• 13.1 DISCUSSION GUIDE
• 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 13.3 CUSTOMIZATION OPTIONS
• 13.4 RELATED REPORTS
• 13.5 AUTHOR DETAILS